Senescence Accelerated Mouse-Prone 8: a Model of Neuroinflammation and Aging with Features of Sporadic Alzheimer’s disease
Stem Cells,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 15, 2025
Abstract
The
large
majority
of
Alzheimer’s
disease
(AD)
cases
are
sporadic
with
unknown
genetic
causes.
In
contrast,
only
a
small
percentage
AD
familial,
known
Paradoxically,
there
few
validated
mouse
models
but
many
familial
AD.
Senescence
Accelerated
Mouse-Prone
8
(SAMP8)
mice
model
accelerated
aging
features
They
exhibit
more
complete
suite
human
AD-relevant
pathologies
than
most
models.
SAMP8
brains
characterized
by
inflammation,
glial
activation,
β-amyloid
deposits,
and
hyperphosphorylated
Tau.
excess
amyloid
deposits
congregate
around
blood
vessels
leading
to
vascular
impairment
leaky
BBBs
in
these
mice.
also
neuronal
cell
death,
feature
not
typically
seen
Additionally,
adult
hippocampal
neurogenesis
is
decreased
correspondingly,
they
have
reduced
cognitive
ability.
line
this,
LTP
significantly
compromised
No
perfect
limited
the
lack
clarity
about
their
genomic
differences
from
control
SAMR1
(Senescence
Mouse-Resistant
1)
although
transcriptomics
changes
being
revealed.
To
further
complicate
matters,
multiple
substrains
emerged
over
years,
sometimes
making
comparisons
studies
difficult.
Despite
challenges,
we
argue
that
can
be
useful
for
studying
symptoms
propose
important
experiments
strengthen
this
already
model.
Язык: Английский
Investigating gut alterations in Alzheimer’s disease: In-depth analysis with micro- and nano-3D X-ray phase contrast tomography
Science Advances,
Год журнала:
2025,
Номер
11(5)
Опубликована: Янв. 31, 2025
Alzheimer’s
disease
(AD),
a
debilitating
neurodegenerative
disorder,
remains
one
of
the
foremost
public
health
challenges
affecting
more
than
30
million
people
worldwide
with
etiology
still
largely
enigmatic.
The
intricate
gut-brain
axis,
serving
as
vital
communication
network
between
gut
and
brain,
appears
to
wield
influence
in
progression
AD.
Our
study
showcases
remarkable
precision
x-ray
phase-contrast
tomography
(XPCT)
conducting
an
advanced
three-dimensional
examination
cellular
composition
structure.
exploitation
micro-
nano-XPCT
on
various
AD
mouse
models
unveiled
relevant
alterations
villi
crypts,
transformations
Paneth
goblet
cells,
along
detection
telocytes,
neurons,
erythrocytes,
mucus
secretion
by
cells
within
cavity.
observed
structural
variations
may
elucidate
transition
from
dysbiosis
neurodegeneration
cognitive
decline.
Leveraging
XPCT
could
prove
pivotal
early
prognosis
disease.
Язык: Английский
Transcriptomic and metabolomic changes might predict frailty in SAMP8 mice
Aging Cell,
Год журнала:
2024,
Номер
23(10)
Опубликована: Июль 3, 2024
Abstract
Frailty
is
a
geriatric,
multi‐dimensional
syndrome
that
reflects
multisystem
physiological
change
and
transversal
measure
of
reduced
resilience
to
negative
events.
It
characterized
by
weakness,
frequent
falls,
cognitive
decline,
increased
hospitalization
dead
represents
risk
factor
for
the
development
Alzheimer's
disease
(AD).
The
fact
frailty
recognized
as
reversible
condition
encourages
identification
earlier
biomarkers
timely
predict
prevent
its
occurrence.
SAMP8
(Senescence‐Accelerated
Mouse
Prone‐8)
mice
represent
most
appropriate
preclinical
model
this
aim
were
used
in
study
carry
transcriptional
metabolic
analyses
brain
plasma,
respectively,
upon
characterization
at
cognitive,
motor,
structural,
neuropathological
level
2.5,
6,
9
months
age.
At
2.5
months,
started
displaying
memory
deficits,
muscle
motor
impairment.
Functional
alterations
associated
with
neurodevelopmental
deficiency
neuronal
density
glial
cell
loss.
Through
transcriptomics,
we
identified
specific
genetic
signatures
well
distinguishing
6
whereas
plasma
metabolomics
allowed
segregate
from
SAMR1
already
age
detecting
constitutively
lower
levels
acylcarnitines
lipids
all
ages
investigated
correlating
functional
deficits
signs.
Our
findings
suggest
central
level,
metabolomic
changes
might
allow
early
assess
frail
leading
dementia
development,
which
paves
foundation
future
investigation
clinical
setting.
Язык: Английский